KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash & Current Investments (2017 - 2025)

Guardant Health (GH) has disclosed Cash & Current Investments for 9 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 43.05% to $1.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, up 43.05% year-over-year, with the annual reading at $1.2 billion for FY2025, 43.05% up from the prior year.
  • Cash & Current Investments hit $1.2 billion in Q4 2025 for Guardant Health, up from $580.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.9 billion in Q1 2021 to a low of $580.0 million in Q3 2025.
  • Historically, Cash & Current Investments has averaged $1.1 billion across 5 years, with a median of $960.2 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: surged 273.1% in 2021 and later crashed 52.35% in 2022.
  • Year by year, Cash & Current Investments stood at $932.7 million in 2021, then rose by 8.41% to $1.0 billion in 2022, then increased by 15.57% to $1.2 billion in 2023, then fell by 28.12% to $840.0 million in 2024, then soared by 43.05% to $1.2 billion in 2025.
  • Business Quant data shows Cash & Current Investments for GH at $1.2 billion in Q4 2025, $580.0 million in Q3 2025, and $629.1 million in Q2 2025.